MSH3 p.Ala58Pro
c.172G>C · rs148550291 · VCV759929
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0847 | likely benign |
|---|---|---|
| REVEL | 0.179 | moderately benign-leaning |
| SaProt | LLR -9.10 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not looked up on this page · why |
| Constraint at this position | ||
| Regional constraint | o/e 1.08 | unconstrained · MANE · 221 kb · p 0.0024 · regional, not allelic |
| Overall | ||
| CADD | 11.72 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.00869% | 11,503 |
| East Asian | 0.00518% | 19,309 |
| Remaining individualsnot grpmax-eligible | 0.00171% | 58,442 |
| European (non-Finnish) | 0.000536% | 186,406 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- MSH3
- Protein
- p.Ala58Pro
- Coding
- c.172G>C
- MANE Select
- NM_000791 · reported on NM_002439
- dbSNP
- rs148550291
- Type
- single nucleotide variant
- Location
- chr5:80654899 (GRCh38)
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/msh3-p-ala58pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown